Sign in

CIK 0001699031 · Non-accelerated filer<br>Emerging growth company

GRAIL, Inc.

Sign in to watch
Ticker
GRAL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863673636
Phone
(833) 694-2553
Business address
250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
Former names
GRAIL, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$14,832,793
in 7 filings, $10.2M under 10b5-1 plans

Net −$14,832,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ofman Joshua J. −$9.2M Chief Executive Officer sold 20% of stake
  2. Freidin Aaron −$4.5M Chief Financial Officer sold 14% of stake
  3. Partridge Andrew John −$1.2M Chief Growth Officer sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2024-06-25 SUMME GREGORY L Director Grant or award +26,470 26,470
2024-06-25 MIZELL STEVEN Director Grant or award +26,470 26,470
2024-06-25 CHASE WILLIAM J Director Grant or award +26,470 26,470
2024-06-24 ILLUMINA, INC. 10% owner Other disposition −26,547,021 4,502,126

Page 8 of 8 · 144 trades